Literature DB >> 35347201

Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study.

Chi-Sheng Wang1, Yen-Wei Pai1,2, Ching-Heng Lin3, I-Te Lee4,5, Ming-Hong Chang6,7.   

Abstract

The relationship between renal impairment and diabetic peripheral neuropathy (DPN) remains inconclusive. We aim to investigate the risk factors for the occurrence of DPN in Taiwanese adults with type 2 diabetes mellitus (T2DM) and focus on renal impairment. A hospital-based study was conducted from 2013 to 2019 and 552 Taiwanese people who had T2DM without DPN at baseline were enrolled. DPN was diagnosed using the Michigan Neuropathy Screening Instrument. Potential risk factors were recorded, including patient's sociodemographic factors, current medication usage and biochemical markers. As of 2019, 73 developed DPN and 479 had no DPN. The cumulative incidence during the 6-year period was 13.22%. Multivariable logistic regression analysis revealed that lower estimated glomerular filtration rate (eGFR) (odds ratio [OR] 0.98, p = 0.005), advanced age (OR 1.06, p = 0.001), increased body weight (OR 1.04, p = 0.018), duration of DM (OR 1.05, p = 0.036) and male gender (OR 3.69, p = 0.011) were significantly associated with future DPN. In addition, patients with T2DM under the age of 65 with higher serum creatinine concentration (OR 8.91, p = 0.005) and higher baseline HbA1C (OR 1.71, p < 0.001) revealed significantly associated with future DPN. In conclusion, this is the first large scaled hospital-based study with long term follow-up to investigate risk factors for DPN in Taiwanese. Lower eGFR and higher serum creatinine concentration, particularly in people under the age of 65, are predictors of future DPN in Taiwanese people with T2DM. Other predictors included advanced age, increased body weight, duration of DM, male gender for all ages and HbA1c in enrolled patients under the age of 65. Our study not only confirms the association between renal impairment and future DPN but also provides a commonly available assessment to predict the future DPN.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35347201      PMCID: PMC8960825          DOI: 10.1038/s41598-022-09333-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  41 in total

1.  Epidemiologic study of type 2 diabetes in Taiwan.

Authors:  C Chang; F Lu; Y C Yang; J S Wu; T J Wu; M S Chen; L M Chuang; T Y Tai
Journal:  Diabetes Res Clin Pract       Date:  2000-10       Impact factor: 5.602

Review 2.  Diabetes Management in Older Adults With Chronic Kidney Disease.

Authors:  Kristin K Clemens; Niamh O'Regan; Jinnie J Rhee
Journal:  Curr Diab Rep       Date:  2019-02-15       Impact factor: 4.810

3.  Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status.

Authors:  Brian C Callaghan; Rong Xia; Mousumi Banerjee; Nathalie de Rekeneire; Tamara B Harris; Anne B Newman; Suzanne Satterfield; Ann V Schwartz; Aaron I Vinik; Eva L Feldman; Elsa S Strotmeyer
Journal:  Diabetes Care       Date:  2016-03-10       Impact factor: 19.112

4.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

5.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

6.  Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.

Authors:  Signe T Andersen; Daniel R Witte; Else-Marie Dalsgaard; Henning Andersen; Peter Nawroth; Thomas Fleming; Troels M Jensen; Nanna B Finnerup; Troels S Jensen; Torsten Lauritzen; Eva L Feldman; Brian C Callaghan; Morten Charles
Journal:  Diabetes Care       Date:  2018-02-27       Impact factor: 19.112

Review 7.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

8.  Structural Nerve Remodeling at 3-T MR Neurography Differs between Painful and Painless Diabetic Polyneuropathy in Type 1 or 2 Diabetes.

Authors:  Johann M E Jende; Jan B Groener; Zoltan Kender; Christian Rother; Artur Hahn; Tim Hilgenfeld; Alexander Juerchott; Fabian Preisner; Sabine Heiland; Stefan Kopf; Peter Nawroth; Martin Bendszus; Felix T Kurz
Journal:  Radiology       Date:  2019-12-31       Impact factor: 11.105

Review 9.  Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention.

Authors:  Dinesh Selvarajah; Debasish Kar; Kamlesh Khunti; Melanie J Davies; Adrian R Scott; Jeremy Walker; Solomon Tesfaye
Journal:  Lancet Diabetes Endocrinol       Date:  2019-10-14       Impact factor: 32.069

10.  A study on the impact of poor medication adherence on health status and medical expense for diabetes mellitus patients in Taiwan: A longitudinal panel data analysis.

Authors:  Chin-Shien Lin; Haider Khan; Ruei-Yuan Chang; Wei-Chih Liao; Yi-Hsin Chen; Sih-Yin Siao; Teng-Fu Hsieh
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.